Citation Impact
Citing Papers
Dual actions of group B Streptococcus capsular sialic acid provide resistance to platelet-mediated antimicrobial killing
2019
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
2017
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Factors involved in the aerosol transmission of infection and control of ventilation in healthcare premises
2006
Heparan Sulfate Proteoglycan Isoforms of the CD44 Hyaluronan Receptor Induced in Human Inflammatory Macrophages Can Function as Paracrine Regulators of Fibroblast Growth Factor Action
2000
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Leptospirosis
2005 Standout
Immune modulation by bacterial outer membrane vesicles
2015
Diagnostic test for etiologic agents of community-acquired pneumonia
2004
Lipid nanoparticles for mRNA delivery
2021 Standout
Airborne transmission of SARS-CoV-2: The world should face the reality
2020 Standout
The use and reporting of multiple imputation in medical research – a review
2010
Extracellular Vesicle RNA: A Universal Mediator of Microbial Communication?
2018 StandoutNobel
Lipid nanoparticle chemistry determines how nucleoside base modifications alter mRNA delivery
2021 StandoutNobel
Etiology of Severe Febrile Illness in Low- and Middle-Income Countries: A Systematic Review
2015
Maternal immunisation: collaborating with mother nature
2017
Alternative splicing in multiple sclerosis and other autoimmune diseases
2010
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
2019
Recent advances in mRNA vaccine technology
2020 StandoutNobel
Respiratory virus shedding in exhaled breath and efficacy of face masks
2020 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Gut microbiome and health: mechanistic insights
2022 Standout
Aerosol Generating Procedures and Risk of Transmission of Acute Respiratory Infections to Healthcare Workers: A Systematic Review
2012 Standout
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
2014 Standout
Major factors affecting the emergence and re-emergence of infectious diseases
2004
The golden age: gold nanoparticles for biomedicine
2011 Standout
Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults
2009
Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
2019
Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis
2009
Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region
2011
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Circular RNAs are abundant, conserved, and associated with ALU repeats
2012 Standout
Superspreading and the effect of individual variation on disease emergence
2005 StandoutNature
The role of vaccines in preventing bacterial antimicrobial resistance
2018
Duration of Humoral Immunity to Common Viral and Vaccine Antigens
2007
Rickettsia honeiInfection in Human, Nepal, 2009
2011
Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions
2015 Standout
Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen
2009 Standout
Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
2013
Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
2018 StandoutNobel
Non-prescription antimicrobial use worldwide: a systematic review
2011
Herpes Zoster
2013 Standout
Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodies
2010
Maternal Immunization
2017
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
2013 Standout
Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations
2015 Standout
Rational design of anti‐inflammatory lipid nanoparticles for mRNA delivery
2022 StandoutNobel
Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation
2006 Standout
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
2016
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota
2008
Actinomyces and Related Organisms in Human Infections
2015 Standout
Investigation of Positron Moderator Materials for Electron-Linac-Based Slow Positron Beamlines
1998
Nucleoside-Modified mRNA-Based Influenza Vaccines Circumvent Problems Associated with H3N2 Vaccine Strain Egg Adaptation
2022 StandoutNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Study of defects in GaN grown by the two-flow metalorganic chemical vapor deposition technique using monoenergetic positron beams
2001 StandoutNobel
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
Classification, Identification, and Clinical Significance of Haemophilus and Aggregatibacter Species with Host Specificity for Humans
2014
Rapid, Sensitive, and Specific Lateral-Flow Immunochromatographic Device To Measure Anti-Anthrax Protective Antigen Immunoglobulin G in Serum and Whole Blood
2006
Vaccine innovations for emerging infectious diseases—a symposium report
2019 StandoutNobel
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Diverse and abundant antibiotic resistance genes in Chinese swine farms
2013 Standout
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi
2015 Standout
Detection of Airborne Severe Acute Respiratory Syndrome (SARS) Coronavirus and Environmental Contamination in SARS Outbreak Units
2005
A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization
2019
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Proteomic Analysis and Immunogenicity of Mannheimia haemolytica Vesicles
2012
Potential Outcome and Directed Acyclic Graph Approaches to Causality: Relevance for Empirical Practice in Economics
2020 StandoutNobel
Update on Tick-Borne Rickettsioses around the World: a Geographic Approach
2013 Standout
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
2003
Chemically Modified Bacterial Sacculi as a Vaccine Microparticle Scaffold
2022 StandoutNobel
The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace
2017 Standout
Airborne transmission of respiratory viruses
2021 StandoutScience
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Re-inventing drug development: A case study of the I-SPY 2 breast cancer clinical trials program
2017
Works of Peter Dull being referenced
Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial
2016
A Multi-Component Meningococcal Serogroup B Vaccine (4CMenB): The Clinical Development Program
2013
The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans
2011
Persistence of immune responses after a single dose of Novartis meningococcal serogroup A, C, W-135 and Y CRM-197 conjugate vaccine (Menveo®) or Menactra® among healthy adolescents
2010
Immune Responses toBacillus anthracisProtective Antigen in Patients with Bioterrorism‐Related Cutaneous or Inhalation Anthrax
2004
Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2–10 years of age
2009
Clinical Features that Discriminate Inhalational Anthrax from Other Acute Respiratory Illnesses
2003
Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial
2016
Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines
2010
Safety and Immunogenicity of a Novel Quadrivalent Meningococcal CRM-conjugate Vaccine Given Concomitantly With Routine Vaccinations in Infants
2011
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials
2013
Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers
2009
Immunogenicity and Immune Memory of a Nonadjuvanted Quadrivalent Meningococcal Glycoconjugate Vaccine in Infants
2009
Immunogenicity of a Tetravalent Meningococcal Glycoconjugate Vaccine in Infants
2008
Complex CD44 splicing combinations in synovial fibroblasts from arthritic joints
1997
Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents
2009
A Randomized Trial to Determine the Tolerability and Immunogenicity of a Quadrivalent Meningococcal Glycoconjugate Vaccine in Healthy Adolescents
2009
Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants
2013
Safety and immunogenicity of an investigational quadrivalent meningococcal CRM197 conjugate vaccine, MenACWY-CRM, compared with licensed vaccines in adults in Latin America
2010
A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women
2016
Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine
2016
Bacillus anthracisAerosolization Associated with a Contaminated Mail Sorting Machine
2002
Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, Menactra
2009
Randomized Trial on the Safety, Tolerability, and Immunogenicity of MenACWY-CRM, an Investigational Quadrivalent Meningococcal Glycoconjugate Vaccine, Administered Concomitantly with a Combined Tetanus, Reduced Diphtheria, and Acellular Pertussis Vaccine in Adolescents and Young Adults
2010
Enhanced slow positron reemission with new thin foil moderator geometry
1990
THE ETIOLOGY OF FEBRILE ILLNESS IN ADULTS PRESENTING TO PATAN HOSPITAL IN KATHMANDU, NEPAL
2004
A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response
2016
First Case of Bioterrorism-Related Inhalational Anthrax in the United States, Palm Beach County, Florida, 2001
2002
High Level of Sequence Diversity in the 16S rRNA Genes of Haemophilus influenzae Isolates Is Useful for Molecular Subtyping
2005